1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Brain-derived neurotrophic factor, neutrophils and cysteinyl leukotriene receptor 1 as potential prognostic biomarkers for patients with colon cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Evaluating the role of leukotriene-modifying drugs in asthma management : Are their benefits ‘losing in translation’?
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Effect of montelukast for treatment of asthma in cigarette smokers
(
- Contribution to journal › Article
- 2009
-
Mark
Montelukast in the treatment of asthma and beyond
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Effects of montelukast and salmeterol on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction
(
- Contribution to journal › Article
- 2000
-
Mark
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial)
(
- Contribution to journal › Article
-
Mark
Montelukast does not affect exercise performance at subfreezing temperature in highly trained non-asthmatic endurance athletes
(
- Contribution to journal › Article